These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 9632993)
21. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization. Biberfield G; Putkonen P; Thorstensson R; Norrby E AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992 [TBL] [Abstract][Full Text] [Related]
22. Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV. Buckner C; Gines LG; Saunders CJ; Vojtech L; Srivastava I; Gettie A; Bohm R; Blanchard J; Barnett SW; Safrit JT; Stamatatos L Virology; 2004 Mar; 320(1):167-80. PubMed ID: 15003872 [TBL] [Abstract][Full Text] [Related]
23. Vaccines against human immunodeficiency virus--progress and prospects. Letvin NL N Engl J Med; 1993 Nov; 329(19):1400-5. PubMed ID: 8413438 [No Abstract] [Full Text] [Related]
24. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic dendritic-cell vaccine for simian AIDS. Lu W; Wu X; Lu Y; Guo W; Andrieu JM Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959 [TBL] [Abstract][Full Text] [Related]
27. Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Putkonen P; Quesada-Rolander M; Leandersson AC; Schwartz S; Thorstensson R; Okuda K; Wahren B; Hinkula J Virology; 1998 Oct; 250(2):293-301. PubMed ID: 9792840 [TBL] [Abstract][Full Text] [Related]
28. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Bomsel M; Tudor D; Drillet AS; Alfsen A; Ganor Y; Roger MG; Mouz N; Amacker M; Chalifour A; Diomede L; Devillier G; Cong Z; Wei Q; Gao H; Qin C; Yang GB; Zurbriggen R; Lopalco L; Fleury S Immunity; 2011 Feb; 34(2):269-80. PubMed ID: 21315623 [TBL] [Abstract][Full Text] [Related]
30. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Cafaro A; Caputo A; Fracasso C; Maggiorella MT; Goletti D; Baroncelli S; Pace M; Sernicola L; Koanga-Mogtomo ML; Betti M; Borsetti A; Belli R; Akerblom L; Corrias F; Buttò S; Heeney J; Verani P; Titti F; Ensoli B Nat Med; 1999 Jun; 5(6):643-50. PubMed ID: 10371502 [TBL] [Abstract][Full Text] [Related]
31. Prospects for vaccine protection against HIV-1 infection and AIDS. Letvin NL; Barouch DH; Montefiori DC Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598 [TBL] [Abstract][Full Text] [Related]
32. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype. Pal R; Kalyanaraman VS; Nair BC; Whitney S; Keen T; Hocker L; Hudacik L; Rose N; Mboudjeka I; Shen S; Wu-Chou TH; Montefiori D; Mascola J; Markham P; Lu S Virology; 2006 May; 348(2):341-53. PubMed ID: 16460776 [TBL] [Abstract][Full Text] [Related]
33. Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates. Waterman PM; Kitabwalla M; Hatfield GS; Evans PS; Lu Y; Tikhonov I; Bryant JL; Pauza CD Viral Immunol; 2004; 17(4):545-57. PubMed ID: 15671751 [TBL] [Abstract][Full Text] [Related]
34. Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx). Igarashi T; Kuwata T; Yamamoto H; Moriyama H; Ui M; Miyazaki Y; Hayami M Microbiol Immunol; 1998; 42(1):71-4. PubMed ID: 9525784 [TBL] [Abstract][Full Text] [Related]
35. Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. McBurney SP; Young KR; Nwaigwe CI; Soloff AC; Cole KS; Ross TM Curr HIV Res; 2006 Oct; 4(4):475-84. PubMed ID: 17073623 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of protection of live attenuated simian immunodeficiency virus: coevolution of viral and immune responses. Cohen GB AIDS; 2010 Mar; 24(5):637-48. PubMed ID: 20186034 [No Abstract] [Full Text] [Related]
39. Development and analysis of recombinant BCG vector systems. Fuerst TR; de la Cruz VF; Bansal GP; Stover CK AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1451-5. PubMed ID: 1466980 [No Abstract] [Full Text] [Related]
40. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies. Warren JT; Dolatshahi M J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]